Patent Yard Sign in
Expired Canadian patentCanada

Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin

CA 2530163 C · Owner: Bradford Pharma Limited · Inventors: Wiffen, Jonathan William; Moody, David John

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

There is provided a process for the preparation of a compound of formula (7) or salts thereof: wherein R1 represents a hydrogen or a hydrocarbyl group R2 , represents a hydrogen or substituent group R3 represents a hydrogen or a , hydrocarbyl group and X represents a hydrogen or substituent group which comprises a) cyanating a compound of formula (1): wherein Y represents a halo group, preferably CI or Br; P1 represents hydrogen or a protecting group and , W represents =0 or -OP2, in which P2 represents hydrogen or a protecting group, to give a compound of formula (2): b) reducing the compound of formula (2) to give a compound of formula (3): coupling the compound of formula (3) with …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 23, 2004 and granted October 2, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 23, 2024.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2026.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 23, 2004
GrantedOctober 2, 2012
Term endedJuly 23, 2024
Patent numberCA 2530163 C
Classification (IPC)C07D207/34 +2 more

Timeline

Timeline From CIPO dates

2005200720092011201320152017201920212023Application filedJuly 23, 2004Patent grantedOct 2, 2012Term endedJuly 23, 2024

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.